"Staffed by chemotherapy-certified oncology registered nurses, the center provides a comfortable, convenient setting for outpatient chemotherapy and infusion services. Laboratory testing and other services are performed as patients rest in comfortable recliners and CBC tests are performed by the Monmouth Medical Center's state-of-the-art laboratory. A host of other services are also provided for non-oncology as well as oncology patients, including IV hydration, iron infusions, colony stimulating factors, lab services, blood draws and central line maintenance."

During the past decade, Rutgers Cancer Institute of New Jersey,100 State Route 36 conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rutgers Cancer Institute of New Jersey,100 State Route 36" #1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Rutgers Cancer Institute of New Jersey,100 State Route 36" are "Triple Negative Breast Cancer" (2 trials), "Cardiotoxicity" (1 trials), "Glioblastoma" (1 trials), "Lung Cancer Stage II" (1 trials) and "Lung Cancer Stage III" (1 trials). Many other conditions were trialed in "Rutgers Cancer Institute of New Jersey,100 State Route 36" in a lesser frequency.

Most popular intervention types in "Rutgers Cancer Institute of New Jersey,100 State Route 36" are "Drug" (3 trials), "Biological" (1 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (2 trials), "Gemcitabine" (2 trials), "Paclitaxel" (2 trials), "Sacituzumab Govitecan-hziy" (2 trials) and "nab-Paclitaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Rutgers Cancer Institute of New Jersey,100 State Route 36" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Rutgers Cancer Institute of New Jersey,100 State Route 36". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were undefined completed trials in Rutgers Cancer Institute of New Jersey,100 State Route 36, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Rutgers Cancer Institute of New Jersey,100 State Route 36, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".